Geiseler - Figure 10
Consequences of Mucus Hypersecretion in COPD
References
[1]
Ha EVS, Rogers DF. Novel therapies to inhibit mucus synthesis and secretion in airway hypersecretory diseases. Pharmacology 2016;97:84–100.
[6]
Putcha N, Han MK, Martinez CH, et al. Comorbidities of COPD have a major impact on clinical outcomes, particularly in African Americans. J COPD F. 2014; 1(1): 105-114.
[7]
Buist AS. The US Lung Health Study. Respirology 1997;2(4):303-307.
[8]
Hartman JE, Prinzen J, van Lummel RC, ten Hacken NHT. Frequent sputum production is associated with disturbed night’s rest an impaired sleep quality in patients with COPD. Sleep Breath 2015;19(4):1125-1133.